Year: 2018
Type: editorial
Abstract: A wealth of tools have been developed that can help pharmacogenomics realize the as-yet-unfulfilled promise of personalizing pharmacotherapy for patients with coronary artery disease (CAD)."
Source: Pharmacogenomics
Authors: Kevin A Friede, Deepak Voora
Institutions: Duke University, Duke Medical Center
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2791350531
